Keros Therapeutics, Inc. (KROS) Insider Trading
Sector: Biotechnology · Market Cap: $230M · 0 insider purchases in the last 7 days
No open market insider purchases at Keros Therapeutics, Inc. in the last 7 days.
Want more?
Sign up free to see 30+ days of history, set alerts, and track KROS on your watchlist.
Start for FreeAbout Keros Therapeutics, Inc. Insider Trading
1 insider at Keros Therapeutics, Inc. (KROS) has purchased stock in the past 90 days, totaling $22K across 2 transactions (2,000 shares).
The most recent purchase was by Director BIENAIME JEAN JACQUES on May 15, 2026 — a $11K buy of 1,000 shares at $10.58, bringing their total holdings to 9,450 shares.
This level of insider buying appears elevated compared to KROS's typical activity — there were 1 purchase in the prior nine months.
KROS is in the Biotechnology sector within the Biotechnology industry with a market cap of $230M.
Track KROS insider trading activity, set up email alerts, and get AI-powered trade analysis with a free Insider Trading Tracker account.